Showing results (241-250 of 282) with videos related to

Sort By:
Pageof 29
The Canadian Journal of Cardiology|November 28, 2017
Endothelial Nitric Oxide Synthase-Induced Hypertrophy and Vascular Dysfunction Contribute to the Left Ventricular Dysfunction in Caveolin-1-/- MiceAnnette Ebner, Nadine Kuerbis, Aljoscha Brandt, et al.
Journal of Cardiovascular Pharmacology|March 12, 2013
Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted miceAnne-Katrin Polanski, Annette Ebner, Bernd Ebner, et al.
Atherosclerosis|February 25, 2014
Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-/- miceMarian Christoph, Karim Ibrahim, Kathleen Hesse, et al.
Cardiology|May 14, 2015
Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone on Peripheral Vessel Function and Clinical Parameters in Nondiabetic Patients: A Double-Center, Randomized Controlled Pilot TrialMarian Christoph, Joerg Herold, Anna Berg-Holldack, et al.
JAMA Network Open|May 29, 2025
Dedicated AI Expert System vs Generative AI With Large Language Model for Clinical DiagnosesMitchell J Feldman, Edward P Hoffer, Jared J Conley, et al.
Journal of Molecular and Cellular Cardiology|April 18, 2008
The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endotheliumCarsten Wunderlich, Kristin Schober, Alexander Schmeisser, et al.
Der Urologe. Ausg. A|November 19, 2004
[Stem cell therapy for urinary incontinence]H Strasser, R Marksteiner, E Margreiter, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 29, 2015
Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillationChristian Pfluecke, Daniel Tarnowski, Lina Plichta, et al.
European Heart Journal. Acute Cardiovascular Care|November 21, 2018
Long term survival after early unloading with Impella CP® in acute myocardial infarction complicated by cardiogenic shockTobias Loehn, William W O'Neill, Bjoern Lange, et al.
Heart and Vessels|February 13, 2014
Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trialMarian Christoph, Joerg Herold, Anna Berg-Holldack, et al.
Pageof 29